LeMaitre Vascular (LMAT) Projected to Post Quarterly Earnings on Thursday

LeMaitre Vascular (NASDAQ:LMAT) is expected to announce its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $0.49 per share and revenue of $55.99 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

LeMaitre Vascular Stock Up 1.9 %

Shares of LMAT stock opened at $104.00 on Wednesday. LeMaitre Vascular has a 12-month low of $61.09 and a 12-month high of $109.58. The company has a market capitalization of $2.34 billion, a P/E ratio of 56.83, a P/E/G ratio of 2.22 and a beta of 0.96. The firm has a 50-day moving average price of $96.23 and a 200 day moving average price of $94.42.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on LMAT shares. Barrington Research lifted their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a report on Friday, November 1st. Wells Fargo & Company began coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 target price for the company. Oppenheimer reiterated an “outperform” rating and set a $93.00 target price (up from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Finally, StockNews.com lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, December 13th. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, LeMaitre Vascular currently has an average rating of “Moderate Buy” and an average price target of $94.63.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.